Cargando…
Novel FIP1L1::KIT fusion in a myeloid neoplasm with eosinophilia, T-lymphoblastic transformation, and dasatinib response
Autores principales: | Alsouqi, Aseel, Kleinberger, Jeffrey, Werner, Taylor S., Awan, Rashid, Chopra, Saurav, Rea, Bryan, Aggarwal, Nidhi, Yatsenko, Svetlana A., Farah, Rafic, Bailey, Nathanael G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620584/ https://www.ncbi.nlm.nih.gov/pubmed/37102594 http://dx.doi.org/10.3324/haematol.2022.282636 |
Ejemplares similares
-
FIP1L1-PDGFRA molecular analysis in the differential diagnosis of eosinophilia
por: Loules, Gedeon, et al.
Publicado: (2009) -
Myeloproliferative neoplasm with eosinophilia and T-lymphoblastic lymphoma with ETV6–LYN gene fusion
por: Telford, N, et al.
Publicado: (2016) -
Case Report: Pediatric myeloid/lymphoid neoplasm with eosinophilia and PDGFRA rearrangement: The first case presenting as B-lymphoblastic lymphoma
por: Akiely, Reem, et al.
Publicado: (2022) -
Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1-PDGFRA-Associated Myeloid Neoplasm With Eosinophilia
por: Jain, Juhi, et al.
Publicado: (2020) -
Expanding dasatinib beyond KIT in acute myeloid leukemia
por: Welch, John S.
Publicado: (2020)